The Australian-based startup has developed its own proprietary large language model to interpret radiology exams

The Stockholm-based startup offers full-body scans capable of detecting health conditions including diabetes and skin cancer.

Healthcare specialist funds of recent vintages performed on par with PE funds investing in other strategies.

The IPO pricing is a reality check that shows even an AI-heavy roadshow pitch must still overcome an unforgiving exit environment for unprofitable VC-backed companies.

What is healthtech in venture capital? Find out more about emerging spaces within the industry and some of the top healthtech companies worldwide backed by VCs.

Prominent athletes are ramping up their investments in the private markets.

Healthcare’s largest industry conference was bereft of major deal announcements and solid indications of IPO plans.

Healthtech—existing at the intersection of biotechnology and care management—has become a VC mainstay.

Telehealth startups, which have been struggling to get back on stable footing after coming down from a pandemic-fueled boom, are eyeing adolescent mental healthcare as a growing opportunity.

One year out from the Dobbs decision leak, investors warn that LP capital into women’s health startups is drying up.

The healthcare services sector still had a robust amount of PE deal activity in 2022, but it wasn’t immune to broader economic uncertainty.

We spoke with VCs active in European healthtech to find out which companies they think represent the cutting edge of healthcare in 2023.

Why is biotech growing so fast? Here we explore how Biotech industry growth continues to be fueled by a growing VC ecosystem.

Paradigm, a healthtech startup that has received a $203 million Series A, is creating technology to match patient records with clinical trial criteria.

Awareness—and VC funding—for femtech startups are on the rise. In this article, we look at 19 female-founded femtech startups.

Healthcare startups show relative resilience amid the market downturn.

We take a look at the largest biotech companies in Switzerland and how they contribute to the industry.

Incredible Health’s $80 million Series B is the latest example of VC appetite for tech-enabled marketplaces, which are trying to help solve the nursing shortage by matching healthcare workers with hospitals.